<DOC>
	<DOCNO>NCT01276951</DOCNO>
	<brief_summary>In Colombia , ischemic heart disease stroke one important cause death 45 year old people . Care case disease represent high cost health system particular society general , due loss productive year life cost care aftermath . Hypertension ( HT ) one preventable risk factor major cerebrovascular disorder . The pathophysiology Essential hypertension complex depend interaction genetic environmental factor . Among determine element increase activity sympathetic nervous system , vasoconstricting overproduction hormone associate sodium retention , disruption renin secretion increase production aldosterone angiotensin II , deregulation kinin system , increase peripheral vascular resistance activity Growth factor atherogenesis vascular endothelial dysfunction , increase cardiac output , diabetes mellitus , obesity , low production vasodilator brain natriuretic peptide ( BNP ) , prostacyclins nitric oxide ( NO ) , among others . Cocoa food rich flavonoid , stimulate enzyme activity endothelial nitric oxide synthase ( e-NOS ) , responsible production NO vascular smooth muscle . The flavonoids modulate synthesis inflammatory substance derive endothelial cell immune system . In recent study find gram cocoa achieves significant reduction blood pressure , investigator propose control clinical trial ass effect different dos cocoa blood pressure endothelial inflammation men essential hypertension , stage I-II without target organ damage , addition pharmacologic monotherapy define management disease . The investigator hope determine optimal dose cocoa , long-term effect , high content flavonoid , improve cardiovascular endothelial parameter advantage economical easy introduction patient 's habit .</brief_summary>
	<brief_title>Controlled Clinical Trial Determine Effective Dose Cocoa Lowering Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male Age : 18 65 year old Resides Medell√≠n City Attached contributive regimen Colombian Health System Essential Arterial Hypertension , stage I II . Be receive pharmacologic therapy ( maximum 2 medication ) , whose dose stable eight week prior study entry . Voluntary desire consume 6,5 ; 12 ; 25 50 gram chocolate per day 18 week . Voluntary desire participate trial sign inform consent . Secondary hypertension Injury target organ : heart , kidney , brain retina Presence diabetes mellitus BMI ( Body Mass Index ) major equal 30 Present smoker less four week abstinence tobacco Consume antiplatelet substance Regular consumption antioxidant multivitamins During study exclude participant present sudden increase blood pressure : SBP great equal 180 mmHg and/or DBP great equal 110 mm Hg .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cocoa</keyword>
	<keyword>Chocolate</keyword>
	<keyword>Endothelial disfunction</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
</DOC>